EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The significance of the apelinergic system in doxorubicin-induced cardiotoxicity

Katarzyna Matusik, Katarzyna Kamińska iD, Aleksandra Sobiborowicz-Sadowska, Hubert Borzuta, Kasper Buczma, Agnieszka Cudnoch-Jędrzejewska

Heart Failure Reviews · 2024

DOI: 10.1007/s10741-024-10414-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, 2024. Verfasst von Katarzyna Matusik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Antibiotics, Antineoplastic, Apelin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is the leading cause of death worldwide, and the number of cancer-related deaths is expected to increase. Common types of cancer include skin, breast, lung, prostate, and colorectal cancers. While clinical research has improved cancer therapies, these treatments often come with significant side effects such as chronic fatigue, hair loss, and nausea. In addition, cancer treatments can cause long-term cardiovascular complications. Doxorubicin (DOX) therapy is one example, which can lead to decreased left ventricle (LV) echocardiography (ECHO) parameters, increased oxidative stress in cellular level, and even cardiac fibrosis. The apelinergic system, specifically apelin and its receptor, together, has shown properties that could potentially protect the heart and mitigate the damages caused by DOX anti-cancer treatment. Studies have suggested that stimulating the apelinergic system may have therapeutic benefits for heart damage induced by DOX. Further research in chronic preclinical models is needed to confirm this hypothesis and understand the mechanism of action for the apelinergic system. This review aims to collect and present data on the effects of the apelinergic system on doxorubicin-induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiotoxicityAntibiotics, AntineoplasticApelinHumansAnimalsOxidative StressNeoplasmsApelin Receptors

Stichwörter der Autor:innen

Apelinergic systemCancerCardiotoxicityDoxorubicin

Substanzen

DoxorubicinAntibiotics, AntineoplasticApelinApelin Receptors

Autor:innen und Institutionen

  • Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
  • Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. kkaminska@wum.edu.pl.

ORCID-Profile: Katarzyna Kamińska

Zitieren

APA

Matusik, K., Kamińska, K., Sobiborowicz-Sadowska, A., Borzuta, H., Buczma, K., & Cudnoch-Jędrzejewska, A. (2024). The significance of the apelinergic system in doxorubicin-induced cardiotoxicity. Heart Failure Reviews. https://doi.org/10.1007/s10741-024-10414-w

Vancouver

Matusik K, Kamińska K, Sobiborowicz-Sadowska A, Borzuta H, Buczma K, Cudnoch-Jędrzejewska A. The significance of the apelinergic system in doxorubicin-induced cardiotoxicity. Heart Failure Reviews. 2024. doi:10.1007/s10741-024-10414-w

BibTeX
@article{Matusik2024,
  author = {Matusik, Katarzyna and Kamińska, Katarzyna and Sobiborowicz-Sadowska, Aleksandra and Borzuta, Hubert and Buczma, Kasper and Cudnoch-Jędrzejewska, Agnieszka},
  title = {The significance of the apelinergic system in doxorubicin-induced cardiotoxicity},
  journal = {Heart Failure Reviews},
  year = {2024},
  doi = {10.1007/s10741-024-10414-w}
}
Kostenlos starten →